News

Neutrolin is a liquid that locks a patient’s central venous catheter (CVC) between hemodialysis (HD) sessions to keep it free of infection and clots. Bruce Cooper, president and

The FDA has approved generic drug following the expiration of pediatric exclusivity associated with the earliest to expire of the patents listed with the FDA for Fosamax, 70mg

Patients receiving once-daily 800mg of IDX899 achieved a mean and median plasma viral load reduction of 2.01 and 2.11 log(10), respectively, after seven days of treatment. Six out

The financial terms of the license agreement includes, an up-front license fee payment to be made by Alphatec to Progressive. Testing, design, regulatory and sales milestone payments that

According to Gary Blick, medical director of Circle Medical, VRX496 appears to cause wt-HIV particles to lose their envelopes and the in vivo pressure delivered by a patient’s

Under the terms of the collaboration, Vermillion will continue to provide financial support, technical assistance and access to its advanced technology platforms, while Johns Hopkins will continue to

In addition to the shares being offered by the company, 83,000 shares will be offered by a selling stockholder. The company will grant the underwriters a 30-day option

In the study, significantly more patients who added vicriviroc 30mg once daily to a new optimized background therapy (OBT) had fully suppressed HIV-RNA (less than 50 copies/ml) at

This agreement expands Meditrina’s clinical stage product portfolio which currently includes Femathina (MPI- 674), an aromatase inhibitor (AI) that Meditrina is repurposing for the treatment of several serious